215 related articles for article (PubMed ID: 22182296)
1. Dopamine transporter gene moderates response to behavioral parent training in children with ADHD: a pilot study.
van den Hoofdakker BJ; Nauta MH; Dijck-Brouwer DA; van der Veen-Mulders L; Sytema S; Emmelkamp PM; Minderaa RB; Hoekstra PJ
Dev Psychol; 2012 Mar; 48(2):567-74. PubMed ID: 22182296
[TBL] [Abstract][Full Text] [Related]
2. Dissecting the attention deficit hyperactivity disorder (ADHD) phenotype: sustained attention, response variability and spatial attentional asymmetries in relation to dopamine transporter (DAT1) genotype.
Bellgrove MA; Hawi Z; Kirley A; Gill M; Robertson IH
Neuropsychologia; 2005; 43(13):1847-57. PubMed ID: 16168728
[TBL] [Abstract][Full Text] [Related]
3. Interacting effects of the dopamine transporter gene and psychosocial adversity on attention-deficit/hyperactivity disorder symptoms among 15-year-olds from a high-risk community sample.
Laucht M; Skowronek MH; Becker K; Schmidt MH; Esser G; Schulze TG; Rietschel M
Arch Gen Psychiatry; 2007 May; 64(5):585-90. PubMed ID: 17485610
[TBL] [Abstract][Full Text] [Related]
4. Behavioral parent training as an adjunct to routine care in children with attention-deficit/hyperactivity disorder: moderators of treatment response.
van den Hoofdakker BJ; Nauta MH; van der Veen-Mulders L; Sytema S; Emmelkamp PM; Minderaa RB; Hoekstra PJ
J Pediatr Psychol; 2010 Apr; 35(3):317-26. PubMed ID: 19633060
[TBL] [Abstract][Full Text] [Related]
5. Association of the dopamine transporter (DAT1) 10/10-repeat genotype with ADHD symptoms and response inhibition in a general population sample.
Cornish KM; Manly T; Savage R; Swanson J; Morisano D; Butler N; Grant C; Cross G; Bentley L; Hollis CP
Mol Psychiatry; 2005 Jul; 10(7):686-98. PubMed ID: 15809660
[TBL] [Abstract][Full Text] [Related]
6. The dopamine transporter gene and the impulsivity phenotype in attention deficit hyperactivity disorder: a case-control association study in a Korean sample.
Kim JW; Kim BN; Cho SC
J Psychiatr Res; 2006 Dec; 40(8):730-7. PubMed ID: 16368111
[TBL] [Abstract][Full Text] [Related]
7. Association between dopamine transporter (DAT1) genotype, left-sided inattention, and an enhanced response to methylphenidate in attention-deficit hyperactivity disorder.
Bellgrove MA; Hawi Z; Kirley A; Fitzgerald M; Gill M; Robertson IH
Neuropsychopharmacology; 2005 Dec; 30(12):2290-7. PubMed ID: 16123773
[TBL] [Abstract][Full Text] [Related]
8. Dopamine transporter genotype influences the physiological response to medication in ADHD.
Gilbert DL; Wang Z; Sallee FR; Ridel KR; Merhar S; Zhang J; Lipps TD; White C; Badreldin N; Wassermann EM
Brain; 2006 Aug; 129(Pt 8):2038-46. PubMed ID: 16760197
[TBL] [Abstract][Full Text] [Related]
9. Variants of the SLC6A3 (DAT1) polymorphism affect performance monitoring-related cortical evoked potentials that are associated with ADHD.
Althaus M; Groen Y; Wijers AA; Minderaa RB; Kema IP; Dijck JD; Hoekstra PJ
Biol Psychol; 2010 Sep; 85(1):19-32. PubMed ID: 20450954
[TBL] [Abstract][Full Text] [Related]
10. Interaction of dopamine transporter genotype with prenatal smoke exposure on ADHD symptoms.
Becker K; El-Faddagh M; Schmidt MH; Esser G; Laucht M
J Pediatr; 2008 Feb; 152(2):263-9. PubMed ID: 18206700
[TBL] [Abstract][Full Text] [Related]
11. Dopaminergic haplotype as a predictor of spatial inattention in children with attention-deficit/hyperactivity disorder.
Bellgrove MA; Johnson KA; Barry E; Mulligan A; Hawi Z; Gill M; Robertson I; Chambers CD
Arch Gen Psychiatry; 2009 Oct; 66(10):1135-42. PubMed ID: 19805704
[TBL] [Abstract][Full Text] [Related]
12. Genetic interaction analysis for DRD4 and DAT1 genes in a group of Mexican ADHD patients.
Gabriela ML; John DG; Magdalena BV; Ariadna GS; Francisco de LP; Liz SM; Lino PC; Josefina RG; Ernesto RZ; Carlos CF
Neurosci Lett; 2009 Feb; 451(3):257-60. PubMed ID: 19146920
[TBL] [Abstract][Full Text] [Related]
13. Spatial attentional bias as a marker of genetic risk, symptom severity, and stimulant response in ADHD.
Bellgrove MA; Barry E; Johnson KA; Cox M; Dáibhis A; Daly M; Hawi Z; Lambert D; Fitzgerald M; McNicholas F; Robertson IH; Gill M; Kirley A
Neuropsychopharmacology; 2008 Sep; 33(10):2536-45. PubMed ID: 18046306
[TBL] [Abstract][Full Text] [Related]
14. Attention-deficit/hyperactivity disorder (ADHD) association with the DAT1 core promoter -67 T allele.
Ohadi M; Shirazi E; Tehranidoosti M; Moghimi N; Keikhaee MR; Ehssani S; Aghajani A; Najmabadi H
Brain Res; 2006 Jul; 1101(1):1-4. PubMed ID: 16782077
[TBL] [Abstract][Full Text] [Related]
15. Association of the risk allele of dopamine transporter gene (DAT1*10) in Omani male children with attention-deficit hyperactivity disorder.
Simsek M; Al-Sharbati M; Al-Adawi S; Ganguly SS; Lawatia K
Clin Biochem; 2005 Aug; 38(8):739-42. PubMed ID: 15993876
[TBL] [Abstract][Full Text] [Related]
16. [Combination of DRD4 and DAT1 genotypes is an important risk factor for attention deficit disorder with hyperactivity families living in Santiago, Chile].
Henríquez B H; Henríquez H M; Carrasco Ch X; Rothhammer A P; Llop R E; Aboitiz F; Rothhammer E F
Rev Med Chil; 2008 Jun; 136(6):719-24. PubMed ID: 18769827
[TBL] [Abstract][Full Text] [Related]
17. Verbal but not performance IQ is highly correlated to externalizing behavior in boys with ADHD carrying both DRD4 and DAT1 risk genotypes.
Kebir O; Grizenko N; Sengupta S; Joober R
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug; 33(6):939-44. PubMed ID: 19409950
[TBL] [Abstract][Full Text] [Related]
18. Evidence of an association between 10/10 genotype of DAT1 and endophenotypes of attention deficit/hyperactivity disorder.
Agudelo JA; Gálvez JM; Fonseca DJ; Mateus HE; Talero-Gutiérrez C; Velez-Van-Meerbeke A
Neurologia; 2015 Apr; 30(3):137-43. PubMed ID: 24461309
[TBL] [Abstract][Full Text] [Related]
19. Association between the dopamine transporter gene and the inattentive subtype of attention deficit hyperactivity disorder in Taiwan.
Shang CY; Gau SS; Liu CM; Hwu HG
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):421-8. PubMed ID: 20800641
[TBL] [Abstract][Full Text] [Related]
20. Dopamine risk and paternal ADHD symptomatology associated with ADHD symptoms in four and a half-year-old boys.
Auerbach JG; Atzaba-Poria N; Berger A; Landau R; Arbelle S; Raz Y; Ebstein R
Psychiatr Genet; 2010 Aug; 20(4):160-5. PubMed ID: 20421851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
